Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis

被引：0
|
作者：
Ashesh B Jani
Christopher M Hand
Charles A Pelizzari
John C Roeske
Lani Krauz
Srinivasan Vijayakumar
机构：
[1] University of Chicago Hospitals,Department of Radiation and Cellular Oncology
来源：
BMC Cancer | / 3卷
关键词：
Prostate Cancer; Dose Volume Histogram; Biological Effective Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [31] GENITOURINARY TOXICITY AFTER HIGH-DOSE-RATE (HDR) BRACHYTHERAPY COMBINED WITH HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: AN ANALYSIS TO DETERMINE THE CORRELATION BETWEEN DOSE-VOLUME HISTOGRAM PARAMETERS IN HDR BRACHYTHERAPY AND SEVERITY OF TOXICITY
    Ishiyama, Hiromichi
    Kitano, Masashi
    Satoh, Takefumi
    Kotani, Shouko
    Uemae, Mineko
    Matsumoto, Kazumasa
    Okusa, Hiroshi
    Tabata, Ken-ichi
    Baba, Shiro
    Hayakawa, Kazushige
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01): : 23 - 28
  • [32] Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy
    Boehmer, D
    Kuczer, D
    Badakhshi, H
    Stiefel, S
    Kuschke, W
    Wernecke, KD
    Budach, V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (05) : 277 - 282
  • [33] Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients
    Moll, Matthias
    Nechvile, Elisabeth
    Kirisits, Christian
    Komina, Oxana
    Pajer, Thomas
    Kohl, Bettina
    Miszczyk, Marcin
    Widder, Joachim
    Knocke-Abulesz, Tomas-Hendrik
    Goldner, Gregor
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (08) : 698 - 705
  • [34] Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: Do we need both?
    Roach, Mack
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (Suppl 2) : 26 - 28
  • [35] Dose Escalated External Beam Radiotherapy versus Neoadjuvant Androgen Deprivation Therapy and Conventional Dose External Beam Radiotherapy for Clinically Localized Prostate Cancer: Do we Need Both?
    Mack Roach
    Strahlentherapie und Onkologie, 2007, 183 : 26 - 28
  • [36] Biological Equivalent Dose (BED) Comparison Between Permanent Interstitial Brachytherapy and Conventional External Beam Radiotherapy for Prostate Cancer
    Liu, X.
    Rahimian, J.
    Cosmatos, H.
    Goy, B.
    Heywood, C.
    Qian, Y.
    MEDICAL PHYSICS, 2014, 41 (06) : 234 - 234
  • [37] High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up
    Hou, Zan
    Li, Guangjun
    Bai, Sen
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (06) : 1063 - 1071
  • [38] High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up
    Zan Hou
    Guangjun Li
    Sen Bai
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1063 - 1071
  • [39] DEVELOPMENT OF LATE TOXICITY AND INTERNATIONAL PROSTATE SYMPTOM SCORE RESOLUTION AFTER EXTERNAL-BEAM RADIOTHERAPY COMBINED WITH PULSED DOSE RATE BRACHYTHERAPY FOR PROSTATE CANCER
    Pieters, Bradley R.
    Rezaie, Elisa
    Geijsen, Elisabeth D.
    Koedooder, Kees
    van der Grient, Johan N. B.
    Blank, Leo E. C. M.
    de Reijke, Theo M.
    Koning, Caro C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 758 - 764
  • [40] Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
    Albert, M
    Tempany, CM
    Schultz, D
    Chen, MH
    Cormack, RA
    Kumar, S
    Hurwitz, MD
    Beard, C
    Tuncali, K
    O'Leary, M
    Topulos, GP
    Valentine, K
    Lopes, L
    Kanan, A
    Kacher, D
    Rosato, J
    Kooy, H
    Jolesz, F
    Carr-Locke, DL
    Richie, JP
    D'Amico, AV
    CANCER, 2003, 98 (05) : 949 - 954
12345